SG11202001602QA - Peptide conjugates, conjugation process, and uses thereof - Google Patents
Peptide conjugates, conjugation process, and uses thereofInfo
- Publication number
- SG11202001602QA SG11202001602QA SG11202001602QA SG11202001602QA SG11202001602QA SG 11202001602Q A SG11202001602Q A SG 11202001602QA SG 11202001602Q A SG11202001602Q A SG 11202001602QA SG 11202001602Q A SG11202001602Q A SG 11202001602QA SG 11202001602Q A SG11202001602Q A SG 11202001602QA
- Authority
- SG
- Singapore
- Prior art keywords
- peptide conjugates
- conjugation process
- conjugation
- conjugates
- peptide
- Prior art date
Links
- 230000021615 conjugation Effects 0.000 title 1
- 239000000863 peptide conjugate Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6018—Lipids, e.g. in lipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ73500817 | 2017-08-30 | ||
PCT/IB2018/056611 WO2019043604A1 (en) | 2017-08-30 | 2018-08-30 | Peptide conjugates, conjugation process, and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202001602QA true SG11202001602QA (en) | 2020-03-30 |
Family
ID=65526296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202001602QA SG11202001602QA (en) | 2017-08-30 | 2018-08-30 | Peptide conjugates, conjugation process, and uses thereof |
Country Status (14)
Country | Link |
---|---|
US (1) | US20200361864A1 (en) |
EP (1) | EP3676250A4 (en) |
JP (1) | JP2020532534A (en) |
KR (1) | KR20200058424A (en) |
CN (1) | CN111247123A (en) |
AU (1) | AU2018323043A1 (en) |
BR (1) | BR112020003907A2 (en) |
CA (1) | CA3073314A1 (en) |
EA (1) | EA202090319A1 (en) |
IL (1) | IL272931A (en) |
MX (1) | MX2020002084A (en) |
SG (1) | SG11202001602QA (en) |
TW (1) | TW201925240A (en) |
WO (1) | WO2019043604A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2020302839A1 (en) * | 2019-06-26 | 2022-01-20 | Ena Respiratory Pty Ltd | Novel molecules |
CN110681362B (en) * | 2019-09-26 | 2020-09-11 | 浙江大学 | Mixed-mode chromatography medium with carboxyl and indolyl as functional groups |
CN111349054A (en) * | 2020-01-21 | 2020-06-30 | 青岛科技大学 | Preparation method of antirust agent 2- (1, 3-benzothiazole-2-sulfenyl) succinic acid |
CA3226951A1 (en) * | 2021-09-02 | 2023-03-09 | Grant MCLACHLAN | Formulation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU776058B2 (en) * | 1999-11-15 | 2004-08-26 | Chancellor, Masters And Scholars Of The University Of Oxford, The | NY-ESO-1 nonapeptide derivatives, and uses thereof |
US20110171259A1 (en) * | 2008-09-05 | 2011-07-14 | Martin Gagne | Novel Compositions and Adjuvants |
JP2012523379A (en) * | 2009-04-09 | 2012-10-04 | ザ ユニバーシティー オブ メルボルン | Immunogenic compositions and uses thereof |
US10576144B2 (en) * | 2013-06-28 | 2020-03-03 | Auckland Uniservices Limited | Amino acid and peptide conjugates and conjugation process |
SG11201807036QA (en) * | 2016-02-26 | 2018-09-27 | Auckland Uniservices Ltd | Amino acid and peptide conjugates and conjugation process |
-
2018
- 2018-08-30 EA EA202090319A patent/EA202090319A1/en unknown
- 2018-08-30 AU AU2018323043A patent/AU2018323043A1/en not_active Abandoned
- 2018-08-30 KR KR1020207009057A patent/KR20200058424A/en unknown
- 2018-08-30 MX MX2020002084A patent/MX2020002084A/en unknown
- 2018-08-30 TW TW107130372A patent/TW201925240A/en unknown
- 2018-08-30 CN CN201880055703.0A patent/CN111247123A/en active Pending
- 2018-08-30 WO PCT/IB2018/056611 patent/WO2019043604A1/en unknown
- 2018-08-30 CA CA3073314A patent/CA3073314A1/en active Pending
- 2018-08-30 EP EP18850403.9A patent/EP3676250A4/en not_active Withdrawn
- 2018-08-30 US US16/638,185 patent/US20200361864A1/en not_active Abandoned
- 2018-08-30 JP JP2020512441A patent/JP2020532534A/en active Pending
- 2018-08-30 BR BR112020003907-1A patent/BR112020003907A2/en not_active Application Discontinuation
- 2018-08-30 SG SG11202001602QA patent/SG11202001602QA/en unknown
-
2020
- 2020-02-26 IL IL272931A patent/IL272931A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN111247123A (en) | 2020-06-05 |
JP2020532534A (en) | 2020-11-12 |
EA202090319A1 (en) | 2020-10-16 |
IL272931A (en) | 2020-04-30 |
US20200361864A1 (en) | 2020-11-19 |
EP3676250A4 (en) | 2021-05-26 |
TW201925240A (en) | 2019-07-01 |
KR20200058424A (en) | 2020-05-27 |
CA3073314A1 (en) | 2019-03-07 |
WO2019043604A1 (en) | 2019-03-07 |
BR112020003907A2 (en) | 2020-09-08 |
AU2018323043A1 (en) | 2020-03-05 |
EP3676250A1 (en) | 2020-07-08 |
MX2020002084A (en) | 2020-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL269283A (en) | Benzazepine compounds, conjugates, and uses thereof | |
HK1259487A1 (en) | Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof | |
IL277748A (en) | Camptothecin peptide conjugates | |
IL279133A (en) | Tumor microenvironment-activated drug-binder conjugates, and uses related thereto | |
HK1247210A1 (en) | Drug conjugates comprising antibodies against claudin 18.2 | |
MX2017011281A (en) | Amatoxin-antibody conjugates. | |
EP3380125A4 (en) | Conjugates comprising peptide groups and methods related thereto | |
IL278877A (en) | Amino-pyrazinecarboxamide compounds, conjugates, and uses thereof | |
IL272931A (en) | Peptide conjugates, conjugation process, and uses thereof | |
IL265471A (en) | Affinity-oligonucleotide conjugates and uses thereof | |
IL264845B1 (en) | Malignant tumor targeting peptides, conjugates and compositions comprising same and uses thereof | |
IL272987A (en) | Mutant fgf-21 peptide conjugates and uses thereof | |
SG11202101517PA (en) | Isoquinoline-steroid conjugates and uses thereof | |
GB201614162D0 (en) | Antibodies, uses thereof and conjugates thereof | |
IL261112A (en) | Amino acid and peptide conjugates and conjugation process | |
SG11202011232VA (en) | Anti-cd63 antibodies, conjugates, and uses thereof | |
IL265645A (en) | Cmet monoclonal binding agents, drug conjugates thereof and uses thereof | |
IL268971A (en) | Polypeptide, polypeptide fragment, derivative thereof, and applications thereof | |
GB201713700D0 (en) | Peptide conjugates | |
GB201801481D0 (en) | Methods, conjugates and systems | |
GB201708105D0 (en) | Antibodies, uses thereof and conjugates thereof | |
GB201817486D0 (en) | Peptides and conjugates | |
GB201805306D0 (en) | Peptides and conjugates | |
GB201818562D0 (en) | Pyrrolobenzodiazephones and conjugates thereof | |
GB201609866D0 (en) | Antibodies, uses thereof and conjugates thereof |